Senior insider sale
CHIEF EXECUTIVE OFFICER at DR REDDYS LABORATORIES LTD — senior position signals high conviction
$13.81M
202.16K shares
What this filing means
ISRAELI EREZ plans to sell 202.16K shares of DR REDDYS LABORATORIES LTD valued at approximately $13.81M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/27/2023ACC: 0001971857-23-000769
Officer· CHIEF EXECUTIVE OFFICER
Since Dec 2025
202.16K
Shares to sell
$13.81M
Approx. market value
5K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
EMPLOYMENT INCOME/STOCK BONUS
EMPLOYMENT INCOME/STOCK BONUS
6/1/2021
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2021 | EMPLOYMENT INCOME/STOCK BONUS EMPLOYMENT INCOME/STOCK BONUS | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
197.16K
Market value
$13.48M
8/4/2023
Planned — Approximate Date
NYSEPlanned
Units to sell
5K
Market value
$327.3K
10/30/2023
Total
Units
202.16K
Value
$13.81M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/4/2023 | 197.16K | $13.48M | — | Completed |
| Planned — Approximate Date | ||||
10/30/2023 | 5K | $327.3K | NYSE | Planned |
| Total | 202.16K | $13.81M | ||